The global Hypoparathyroidism Treatment Market is witnessing steady growth, with market value estimated at USD 785.7 million in 2025 and projected to reach USD 1.15 billion by 2035, growing at a CAGR of 3.9% during the forecast period. Growth is being driven by increasing prevalence of hypoparathyroidism, rising post-surgical endocrine disorder cases, advancements in recombinant parathyroid...